S100A14 and breast cancer: Tanaka et al. performed immunohistochemical analysis of S100A14 in archival specimens of primary tumors of 167 breast cancer patients and found that 53% of cases expressed strong, predominantly membranous S100A14, while the control normal tissue showed no or faint staining [81].